Form 4: SI-BONE Director Daniel Wolf Receives Equity Grant of 8,675 Restricted Stock Units

SI-BONE, Inc. Director Daniel W. Wolf was granted 8,675 restricted stock units, vesting upon the earlier of the next annual general meeting or one year from the vesting commencement date, as disclosed in a recent SEC Form 4 filing.

Summary

• Daniel W. Wolf, a Director of SI-BONE, Inc. (SIBN), acquired 8,675 shares of common stock on June 5, 2025, at a price of $0.00 per share.
• These shares represent restricted stock units (RSUs) granted to Mr. Wolf.
• Each RSU provides a contingent right to receive one share of the Issuer's common stock.
• The 8,675 RSUs will vest 100% upon the earlier of the Company's next annual general meeting of stockholders or one year from the Vesting Commencement Date, contingent on Mr. Wolf's continuous service on the Board of Directors.
• Following this transaction, Mr. Wolf beneficially owns a total of 25,857 shares, which includes 22,993 shares issuable from previously granted restricted stock units.

Sentiment

Score: 7

Explanation: The document reports a routine equity compensation grant to a director, which is a positive for aligning interests and retaining talent, but it does not contain significant new financial or operational information that would dramatically alter the company's outlook. It's a standard corporate governance disclosure.

Positives

• The grant of restricted stock units aligns the director's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The vesting schedule encourages long-term commitment and continuous service from the director.

Negatives

• The issuance of new shares upon vesting of RSUs could lead to minor dilution for existing shareholders, although the amount is small in this instance.

Risks

• The vesting of the restricted stock units is contingent on Daniel Wolf's continuous service as a member of the Company's Board of Directors.

Future Outlook

The vesting of the granted restricted stock units is tied to future events, specifically the next annual general meeting of stockholders or one year from the vesting commencement date, indicating a forward-looking compensation structure for the director.

Industry Context

This transaction is a standard form of equity compensation for directors in publicly traded companies, commonly used across various industries to align director incentives with shareholder value creation and ensure retention.

Corporate Governance

Related Party Transactions

• The grant of 8,675 restricted stock units to Daniel Wolf, a Director of SI-BONE, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board.

Stakeholder Impact

• Shareholders: Minor potential for dilution upon RSU vesting, but overall positive impact due to enhanced director alignment with shareholder interests and retention.

Next Steps

• The restricted stock units are expected to vest 100% upon the earlier of the next annual general meeting of SI-BONE, Inc. stockholders or one year from the Vesting Commencement Date.

Key Dates

Recommendation

Keywords

SI-BONE, SIBN, Form 4, Restricted Stock Units, RSU, Equity Grant, Director Compensation, Beneficial Ownership, SEC Filing, Corporate Governance, Stock Compensation